about
Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-AnalysisNew Insights into the Management of Patients with Autoimmune Diseases or Inflammatory Disorders During PregnancyThe role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literatureHepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-ScreenedTowards personalized medicine for patients with autoimmune diseases: Opportunities and challenges.Interleukin 21 as a new possible player in pemphigus: Is it a suitable target?The dual nature of retinoic acid in pemphigus and its therapeutic potential: Special focus on all-trans Retinoic Acid.Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.The possible role of interleukin-35 and its therapeutic potential in pemphigus.Management of pemphigus disease in pregnancy.Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection.Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy.Association of Plasma Levels of Vitamin D With Chronic Hepatitis B InfectionNucleoside/nucleotide analogues in the treatment of chronic hepatitis B infection during pregnancy: a systematic review.Changes in induced regulatory T cells by interleukin 35 during atopic dermatitis.Regulatory Responses during Chronic Hepatitis B Virus Infection.The new insight into management of hepatitis B virus patients with flare.Inhibition of regulatory cells as a possible cure of chronically hepatitis B virus infected patients.Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review.Current and future treatment options for pemphigus: Is it time to move towards more effective treatments?Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.The ignored roles of microRNAs in alopecia areata.Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus.Corrigendum to "The possible role of interleukin-35 and its therapeutic potential in pemphigus" [Int. Immunol. 42 (2017) 11-17].Complex Interaction Between Diphenylcyclopropenone and Immune Responses in Alopecia Areata.Cryotherapy plus oral zinc sulfate versus cryotherapy plus placebo to treat common warts: A double blind, randomized, placebo-controlled trial.Janus Kinase Inhibitors against Other Biological Treatments in Alopecia Areata.Lichen planopilaris: Retrospective study on the characteristics and treatment of 291 patientsDupilumab: a revolutionary emerging drug in atopic dermatitis and its possible role in pemphigusPathogenic and protective roles of cytokines in pemphigus: A systematic reviewTreatment of port wine stains with 595-nm pulsed dye laser in 27 pediatric patients: A prospective study in the Iranian populationComparing early and late treatments with rituximab in pemphigus vulgaris: which one is better?Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six monthsOral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: A randomized controlled trial"Change over time in the treatment of pemphigus vulgaris between 2004 and 2016 in Iran": A multiple cross-sectional studyTofacitinib as the potent treatment for refractory pemphigus: A possible alternative treatment for pemphigusIranian guideline for rituximab therapy in pemphigus patientsAnti-desmoglein-1 levels as predictor of prednisolone tapering in pemphigus vulgaris patients treated with rituximabSingle-nucleotide polymorphisms associated with pemphigus vulgaris: Potent markers for better treatment and personalized medicineThe elevated level of osteopontin in patients with pemphigus vulgaris: A cytokine-like protein with a therapeutic potential
P50
Q26743425-E4A8DDF5-692A-4D4B-981A-B13A7FF1B22CQ26746102-58856D11-C16A-4517-95C2-18D346EEF735Q28067526-99511181-26E9-477F-A17D-46B09B112036Q28076703-DE56E8DD-2301-40A0-A652-5027E4D041D1Q38644182-1265A0A6-9F9F-476F-9A51-F1E85AD36AA6Q38761995-22F0F1C3-8162-4BC3-9BB0-55E8F788123EQ38828465-7FF59CBA-2710-4DB7-9E74-A37E7CB4F808Q38908249-303096B2-C739-42E8-B18D-33338D5B5DFAQ39010829-1D8F84AB-46DD-4E83-A708-7F11C14419E6Q39013055-E8E96A8E-8E44-49EC-B803-248D7FE66884Q39388052-EE59F2CC-0F63-4CA5-887D-D5A9DC2059C6Q39512705-DAF176A7-DDCC-40BC-A130-4F9DCF56506BQ39512724-9C6AB3D7-BDE3-4E08-9095-D4780640C1EDQ41918890-51B6FB7C-3DA5-4EF6-80A1-6E6F7CB67CC1Q42377618-4ABFC461-1BCA-4E47-938F-66D90A4E1822Q45330792-3D07C440-DA45-426C-9D71-C8F30D1CA35BQ45338108-8254156C-3F6A-496D-BA53-A35C94E0883BQ45339229-DF6690E8-7FD3-45D8-9D11-5CBBDD419568Q47582123-729AD173-A60E-4F56-99B1-B54E85DD48F6Q47857333-DF53ECD1-826A-4800-81C7-544188760268Q48197650-585CB8D4-7D67-4856-B862-7998A2043E51Q48286893-8A2427AD-C7D8-4AA9-B50A-66FCAEE18EE0Q48354790-7DFD62F8-CEF3-413D-94F2-47C4EDAF6F73Q50133497-286A34C6-3AF8-4CE1-8C99-C60E60AFBE92Q51585840-C69BF2F9-2621-4AD0-9373-C8E8B4D490E4Q54967079-27F6C210-EE7B-4572-94DC-96C44EAD2D10Q55027127-8C6B1941-90A5-4B01-8266-4F7B4802363AQ58565893-EAD5AA6B-455C-43F5-9F98-56C66D666668Q87140474-879A281A-CABD-4E06-8F41-08B9C0B87904Q89714588-98A53DD4-8CBE-4372-8A39-876357EA7A38Q90118768-422526CA-F3A4-46D7-B25C-1A4ACDE87CF3Q90129393-84EF8C3E-FC8D-4083-93E2-91112C81D6F8Q90780511-44027A5F-1B6A-4AC0-A86D-F15A277ADD04Q90830095-5E2512EB-2580-410E-979E-E4B7B2F86E56Q91120051-AB911BC0-4D23-4A99-B78E-5B6EC139AA03Q91397732-9874B0DD-0757-47B7-9C18-87EB913C5E64Q91585295-BBB04FF1-3947-4DD0-9635-D8A92EB42163Q91678056-EEB7C5F4-7D0C-44DA-87A3-928D6CA91B0AQ92163771-2DF6F78C-9D01-44C3-BED4-3CA9F82A3A53Q92343582-FA2B91A4-70E7-48EC-818F-71508B0B6E14
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
پژوهشگر
@fa
name
Soheil Tavakolpour
@ast
Soheil Tavakolpour
@en
Soheil Tavakolpour
@es
Soheil Tavakolpour
@nl
Soheil Tavakolpour
@sl
سهیل توکل پور
@fa
type
label
Soheil Tavakolpour
@ast
Soheil Tavakolpour
@en
Soheil Tavakolpour
@es
Soheil Tavakolpour
@nl
Soheil Tavakolpour
@sl
سهیل توکل پور
@fa
prefLabel
Soheil Tavakolpour
@ast
Soheil Tavakolpour
@en
Soheil Tavakolpour
@es
Soheil Tavakolpour
@nl
Soheil Tavakolpour
@sl
سهیل توکل پور
@fa
P106
P31
P3835
soheil-tavakolpour
P496
0000-0002-6765-8830